Works by Hou, Jianguo


Results: 37
    1
    2
    3
    4
    5
    6
    7
    8

    Proxalutamide in metastatic castration‐resistant prostate cancer: Primary analysis of a multicenter, randomized, open‐label, phase 2 trial.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 4, p. 792, doi. 10.1002/ijc.34512
    By:
    • Zhou, Tie;
    • Qin, Shengfei;
    • Xu, Weidong;
    • Tang, Shouyan;
    • Chen, Guanghua;
    • Li, Song;
    • Hou, Jianguo;
    • Gao, Xu;
    • Shi, Guowei;
    • Sun, Zhongquan;
    • Jin, Jie;
    • Chen, Lijun;
    • Sun, Weibing;
    • Liu, Ben;
    • Wang, Jingen;
    • Meng, Qinggui;
    • Wang, Dongwen;
    • Hu, Zhiquan;
    • He, Dalin;
    • Yang, Yong
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37